{
  "id": "dbeacc70fbfd023b",
  "title": "ImmunityBio Engages FDA on ANKTIVA\u00ae Resubmission for Bladder Cancer Treatment",
  "description": "20260120T174500Z",
  "content": "",
  "source": "el-balad.com",
  "source_url": "https://www.el-balad.com/6827781",
  "published_at": "20260120T174500Z",
  "fetched_at": "2026-01-21T00:24:36.527019+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "Egypt",
  "raw_data": {
    "url": "https://www.el-balad.com/6827781",
    "url_mobile": "",
    "title": "ImmunityBio Engages FDA on ANKTIVA\u00ae Resubmission for Bladder Cancer Treatment",
    "seendate": "20260120T174500Z",
    "socialimage": "https://www.el-balad.com/uploads/images/202601/image_1200x675_696fba7017ff4.webp",
    "domain": "el-balad.com",
    "language": "English",
    "sourcecountry": "Egypt"
  }
}